Revanesse Outline+ (w/Lidocaine) Kit 2x1.2ml 29G

4.6 6

2 x 1.2ml

Revanesse Outline+ with Lidocaine is a high viscosity HA gel optimized with Thixofix® cross-linking technology for medium to deep facial rhytides. As a smooth and viscous gel, Outline™ is ideal for creating defined vermillion borders and vertical lift, as well as correcting deep tissue areas that require large, volumetric adjustments.

Revanesse Outline+ with Lidocaine


Injection depth - Deep Dermis-to-Subcutaneous


Important Characteristics
• High molecular weight HA for minimizing the inflammatory response
• Optimal cohesivity for adapting to the surrounding tissue and injection depth
• Smooth & uniform injection for accuracy and precision
• Round & smooth HA particles for minimizing the inflammatory response
• High yield stress for shape retention in very deep tissue areas
• High elasticity (G’) for stiffness (lift capacity)


Uniformity and Consistency
Consistency in shape and texture enables Outline™ to flow smoothly from the syringe despite being viscous and having a large average particle size.


Why Outline™?
• Ideal physicochemical properties for stiffness (lift capacity) and shape retention
• Optimal integration into the perioral matrix, dermal matrix and subcutaneous
• Designed for safety with round and smooth HA particles


Manufacturer: Prollenium Medical Technologies Inc.

Brand

Revanesse

Composition

HA 25 mg/ml, Lidocaine 0,3%

Biodegradation period

18 - 24 months

Technology

Thixofix cross-linking technology

Packaging

2 syringes х 1.2 ml

Needle size

27G,29G

Product type

Dermal filler

Application areas

Face,Cheeks,Chin,Temples,Jawline

Contraindications

The product isn't intended for personal use due to certain restrictions, and should only be administered by a trained medical specialist.

Manufacturer

Prollenium Medical Technologies

Country of origin

Canada

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provided both a filter and a template to use.

ALTERNATIVE PRODUCTS